Number and tumor size are not sufficient criteria to select patients for liver transplantation for hepatocellular carcinoma

Annals of Surgical Oncology

Volumn 19, Issue 6, 2012, Pages 2020-2026

  Piardi, T ^a   Gheza, F ^a   Ellero, B ^a   Woehl Jaegle, M L ^a   Ntourakis, D ^a   Cantu, M ^a   Marzano, E ^a   Audet, M ^a   Wolf, P ^a   Pessaux, Patrick ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CANCER SURVIVAL; DISEASE CLASSIFICATION; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PATIENT SELECTION; RETROSPECTIVE STUDY;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PATIENT SELECTION; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; SAN FRANCISCO; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84865136923     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-011-2170-9     Document Type: Article

References (43)

1. Belghiti J, Panis Y, Farges O, Benhamou JP, Fekete F. Intrahe-patic recurrence after resection of hepaocellular carcinoma complicating cirrhosis. Ann Surg. 1991;214:114-7.
2. Mazzaferro V, Regalia E, Doci R, et al. Liver Transplantation for the treatment of small hepatocellular carcinoma in patients with cirrhosis. N Engl J Med. 1996;334:693-9. (Pubitemid 26079803)
3. Schwartz ME, D'Amico F, Vitale A, Emre S, Cillo U. Liver transplantation for hepatocellular carcinoma: are the Milan criteria still valid? Eur J Surg Oncol. 2008;34:256-62. (Pubitemid 351312865)
4. Duffy JP, Vardanian A, Benjamin E, et al. Liver transplantation criteria for hepatocellular carcinoma should be explained: a 22-year experience with 467 patients at UCLA. Ann Surg. 2007; 246:502-9. (Pubitemid 47312148)
5. Piardi T, Audet M, Odeh M, et al. Liver transplantation exceeding UCSF criteria: case repost of a late recurrence treated by surgery and review of the literature. Eur Surg Res. 2010; 44:52-5.
6. Pawlik TM, Delman KA, Vauthey JN, et al. Tumor size predicts vascular invasion and histologic grade: implication for selection of surgical treatment for hepatocellular carcinoma. Liver Transpl. 2005;11:1086-92. (Pubitemid 41341758)
7. Mazzaferro V, Llovet JM, Miceli R, et al. Predicting survival after live transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009;10:35-42.
8. Bruix J, Sherman M, Llovet M, et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol. 2001;35:421-30. (Pubitemid 32844200)
9. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology. 2001;33:1394-403. (Pubitemid 32496976)
10. Audet M, Piardi T, Panaro F, et al. Four hundred and twenty-three consecutive adults piggy-back liver transplantations with the three suprahepatic veins: was the portal systemic shun required? J Gastroenterol Hepatol. 2010;25:591-6.
11. Edmonson HA. Primary carcinoma of the liver: a study of 100 cases among 48, 900 necropsies. Cancer. 1954;7:462-503.
12. Ikai I, Yamamoto Y, Yamamoto N, et al. Results of hepatic resection for hepatocellular carcinoma invading major portal and/or hepatic veins. Surg Oncol Clin N Am. 2003;12:65-75. (Pubitemid 36204980)
13. Hermanek P, Hendson D, Hutter R. TNM supplement 1993: a commentary on uniform use. Berlin: Springer-Verlag, 1993.
14. AJCC Cancer staging handbook. TNM liver classification. In: Greene FL, Page DL, Fleming ID, et al., editors. American Joint Committee on Cancer (AJCC) cancer staging manual. 6th ed. New York: Springer-Verlag, 2005:1208-36.
15. Anderson TW. On the distribution of the two-sample Cramer-von Mises criterion. Ann Math Stat. 1962;33:1148-59.
16. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma:resection versus transplantation. Hepatology. 1999;30:1434-40.
17. Neuberger J. Liver-cell cancer and transplantation. Lancet Oncol. 2009;10:5-7.
18. Washburn K, Edwards E, Harper A, et al. Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system. Am J Transplant. 2010;10:1643-8.
19. Yao FY, Hirose R, La Berge JM, et al. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl. 2005;11:1505-14. (Pubitemid 43072626)
20. Dubay D, Sandroussi C, Sandhu L, et al. Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion. Ann Surg. 2011;253:166-72.
21. Cillo U, Vitale A, Bassanello M, et al. Liver transplantation for the treatment of moderately or well-differentiated heptocellurlar carcinoma. Ann Surg. 2004;239:150-9. (Pubitemid 38176347)
22. Shah SA, Tan JC, McGilvray ID, et al. Accuracy of staging as a predictor for recurrence after liver transplantation for hepatocel-lular carcinoma. Transplantation. 2006;81:1633-9. (Pubitemid 43948294)
23. D'Amico F, Schwartz M, Vitale A, et al. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. Liver Transpl. 2009;15: 1278-87.
24. Lai Q, Merli M, Corradini S, et al. Predictive factors of recurrence of hepatocellular carcinoma after liver transplantation: a multivariate analysis. Transpl Proc. 2009;41:1306-9.
25. Jonas S, Bechstein WO, Steinmuller T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepa-tology. 2001;33:1080-6. (Pubitemid 32378206)
26. Schwartz M. Liver transplantation: the preferred treatment for early hepatocellular carcinoma in the setting of cirrhosis? Ann Surg Oncol. 2005;14:548-52.
27. Pomfret EA, Washburn K, Wald C, et al. Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl. 2010;16:262-78.
28. Salizzoni M, Romagnoli R, Lupo F, et al. Microscopic vascular invasion detected by anti-CD34 immunohistochemistry as a predictor of recurrence of hepatocellular carcinoma after liver transplantation. Transplantation. 2003;76:844-8. (Pubitemid 37140230)
29. Sumie S, Kuromatsu R, Okuda K, et al. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clini-copathological factors. Ann Surg Oncol. 2008;15:1375-82.
30. Lohe F, Angele MK, Rentsch M, et al. Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation. Clin Transplant. 2007;21:696-71.
31. Parfitt JR, Marotta P, AlGhamdi M, et al. Recurrent hepatocel-lular carcinoma after transplantation: use of a pathological score on explanted livers to predict recurrence. Liver Transpl. 2007; 13:543-51. (Pubitemid 46605857)
32. Shetty K, Timmins K, Brensinger C, et al. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl. 2004;10:911-8. (Pubitemid 38979263)
33. Vibert E, Azoulay D, Hoti E, et al. Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor. Am J Transplant. 2010;10:129-37.
34. Klintmalm GB. Liver Transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg. 1998;228:479-90. (Pubitemid 30194392)
35. Chen JWC, Kow L, Verran DJ, et al. Poorer survival in patients whose explanted hepatocellular carcinoma (HCC) exceeds Milan or UCSF criteria. An analysis of liver transplantation in HCC in Australia and New Zealand. HPB (Oxford). 2009;11:81-9.
36. Pawlik T, Glaintzner AL, Anders RA, Assumpcao L, Maley W, Choty MA. Preoperative assessment of hepatocellular carcinoma tumor grade using needle biopsy. Ann Surg. 2007;245:435-42. (Pubitemid 46673140)
37. Belghiti J. Resection and liver transplantation for HCC. Gastro-enterology. 2009;44(Suppl. 19):132-5.
38. Azagra JS, Goergen M, Gilbart E, et al. Laparoscopic anatomical (hepatic) left lateral segmentectomy-technical aspects. Surg Endosc. 1996;10:758-61. (Pubitemid 126469668)
39. Huscher CG, Lirici MM, Chiodini S. Laparoscopic liver resections. Semin Laparosc Surg. 1998;5:204-10.
40. Buell JF, Cherqui D, Geller DA. The international position on laparoscopic liver surgery. Ann Surg. 2009;250:825-30.
41. Dagher I, Belli G, Fantini C, et al. Laparoscopic hepatectomy for hepatocellular carcinoma: a European experience. J Am Coll Surg. 2010;211:16-23.
42. Belghiti J, Durand F. Criteria for liver transplantation for hepa-tocellular carcinoma: what is an acceptable outcome. Liver Int. 2011;31(Suppl. 1):161-3.
43. Durand F, Belghiti J, Paradis V. Liver transplantation for hepato-cellular carcinoma: role of biospy. Liver Transpl. 2007;13:S17-23.